Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse

Bone Marrow Transplantation

Volumn 45, Issue 10, 2010, Pages 1546-1552

  Thiant, S ^a,b   Yakoub Agha, I ^a,b   Magro, L ^b   Trauet, J ^b   Coiteux, V ^b   Jouet, J P ^a,b   Dessaint, J P ^a,b   Labalette, M ^a,b  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

acute GVHD; allo SCT; IL 15; IL 7; relapse

Indexed keywords

BIOLOGICAL MARKER; CYCLOSPORIN; INTERLEUKIN 15; INTERLEUKIN 7; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER REGRESSION; CANCER RELAPSE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; MALE; MYELOABLATIVE CONDITIONING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; CHILD; EARLY DIAGNOSIS; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY; HUMANS; INTERLEUKIN-15; INTERLEUKIN-7; KINETICS; LYMPHOPENIA; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; NEOPLASM RECURRENCE, LOCAL; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 77957965347     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.13     Document Type: Article

References (40)

1. Bleakley M, Riddell SR. Molecules and mechanisms of the graft-versus-leukaemia effect. Nat Rev Cancer 2004; 4: 371-380.
2. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol 2007; 7: 340-352.
3. Boyiadzis M, Memon S, Carson J, Allen K, Szczepanski MJ, Vance BA et al. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is asso-ciated with elevated IL-15 levels. Biol Blood Marrow Trans-plant 2008; 14: 290-300.
4. Storek J, Geddes M, Khan F, Huard B, Helg C, Chalandon Y et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 2008; 30: 425-437.
5. Fry TJ, Mackall CL. Immune reconstitution following hematopoietic progenitor cell transplantation: challenges for the future. Bone Marrow Transplant 2005; 35(Suppl 1): S53-S57.
6. Williams KM, Hakim FT, Gress RE. T cell immune reconstitution following lymphodepletion. Semin Immunol 2007; 19: 318-330.
7. Snyder KM, Mackall CL, Fry TJ. IL-7 in allogeneic transplant: clinical promise and potential pitfalls. Leuk Lymphoma 2006; 47: 1222-1228.
8. Fry TJ, Mackall CL. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 2005; 174: 6571-6576.
9. Alpdogan O, Eng JM, Muriglan SJ, Willis LM, Hubbard VM, Tjoe KH et al. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 2005; 105: 865-873.
10. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001; 97: 14-32.
11. Dean RM, Fry T, Mackall C, Steinberg SM, Hakim F, Fowler D et al. Association of serum interleukin-7 levels with the development of acute graft-versus-host disease. J Clin Oncol 2008; 26: 5735-5741.
12. Kumaki S, Minegishi M, Fujie H, Sasahara Y, Ohashi Y, Tsuchiya S et al. Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children. Int J Hematol 1998; 67: 307-312.
13. Sakata N, Yasui M, Okamura T, Inoue M, Yumura-Yagi K, Kawa K. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease. Bone Marrow Trans-plant 2001; 27: 1153-1161.
14. Chik KW, Li K, Pong H, Shing MM, Li CK, Yuen PM. Elevated serum interleukin-15 level in acute graft-versus-host disease after hematopoietic cell transplantation. J Pediatr Hematol Oncol 2003; 25: 960-964.
15. low NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J Immunol 2008; 181: 2227-2237.
16. Abu-Ghosh A, Goldman S, Slone V, van de Ven C, Suen Y, Murphy L et al. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplant-ation. Bone Marrow Transplant 1999; 24: 535-544.
17. Bolotin E, Annett G, Parkman R, Weinberg K. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999; 23: 783-788.
18. + T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia 2006; 20: 1557-1565.
19. Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 2009; 206: 25-34.
20. de Vries E, van Tol MJ, van den Bergh RL, Waaijer JL, ten Dam MM, Hermans J et al. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation. Bone Marrow Transplant 2000; 25: 267-275.
21. Olkinuora H, Talvensaari K, Kaartinen T, Siitonen S, Saarinen-Pihkala U, Partanen J et al. T cell regeneration in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 39: 149-156.
22. + T cells on relapse. Biol Blood Marrow Transplant 2009; 15: 496-504.
23. Sportes C, Hakim FT, Memon SA, Zhang H, Chua KS, Brown MR et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008; 205: 1701-1714.
24. Gendelman M, Hecht T, Logan B, Vodanovic-Jankovic S, Komorowski R, Drobyski WR. Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease. J Immunol 2004; 172: 3328-3336.
25. 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 37: 1119-1128.
26. Savani BN, Mielke S, Rezvani K, Montero A, Yong AS, Wish L et al. Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 1216-1223.
27. + cell count and transplant-related mortality. Bone Marrow Trans-plant 2008; 41: 55-62.
28. + naive T cells: potential for adoptive immunotherapy and allodepletion. Blood 2004; 104: 2403-2409.
29. Macedo C, Orkis EA, Popescu I, Elinoff BD, Zeevi A, Shapiro R et al. Contribution of naive and memory T-cell populations to the human alloimmune response. Am J Transplant 2009; 9: 2057-2066.
30. hi T cells. Eur J Immunol 2008; 38: 30-39.
31. Shamim Z, Ryder LP, Heilmann C, Madsen H, Lauersen H, Andersen PK et al. Genetic polymorphisms in the genes encoding human interleukin-7 receptor-α: prognostic signifi-cance in allogeneic stem cell transplantation. Bone Marrow Transplant 2006; 37: 485-491.
32. + T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease. JImmunol 2007; 179: 3305-3314.
33. Chu YW, Memon SA, Sharrow SO, Hakim FT, Eckhaus M, Lucas PJ et al. Exogenous IL-7 increases recent thymic emigrants in peripheral lymphoid tissue without enhanced thymic function. Blood 2004; 104: 1110-1119.
34. Fallen PR, McGreavey L, Madrigal JA, Potter M, Ethell M, Prentice HG et al. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003; 32: 1001-1014.
35. Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, Milpied N et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 2006; 24: 5695-5702.
36. + T cells in vitro. Blood 2003; 102: 2541-2546.
37. Sandau MM, Winstead CJ, Jameson SC. IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8T cells. J Immunol 2007; 179: 120-125.
38. + memory T cells mediated by IL-15 and its induced cytokines. JImmunol 2006; 177: 7802-7810.
39. Ishaqi MK, Afzal S, Dupuis A, Doyle J, Gassas A. Early lymphocyte recovery post-allogeneic hematopoietic stem cell transplantation is associated with significant graft-versus-leukemia effect without increase in graft-versus-host disease in pediatric acute lymphoblastic leukemia. Bone Marrow Transplant 2008; 41: 245-252.
40. Savani BN, Mielke S, Adams S, Uribe M, Rezvani K, Yong AS et al. Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lympho-blastic leukemia. Leukemia 2007; 21: 2145-2152.